STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 20/301% above fair value
$264.32+10.88 (+4.29%)
Close on Nov 13, 2026Market cap $25.77BP/E 31.4Yield 0.93%
Steris operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Steris's operating cash flow for the twelve months ending Sep 30, 2026 was $1.29B, down 0.9% year over year. For fiscal 2026 it was $1.34B, up 16.8% from the year before. The highest annual figure on record is $1.34B in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.34B | +16.8% |
| FY2025 | Mar 31, 2025 | $1.15B | +18.0% |
| FY2024 | Mar 31, 2024 | $973.30M | +28.6% |
| FY2023 | Mar 31, 2023 | $756.95M | +10.5% |
| FY2022 | Mar 31, 2022 | $684.81M | -0.7% |
| FY2021 | Mar 31, 2021 | $689.64M | +16.8% |
| FY2020 | Mar 31, 2020 | $590.56M | +9.5% |
| FY2019 | Mar 31, 2019 | $539.51M | +17.9% |
| FY2018 | Mar 31, 2018 | $457.63M | +7.9% |
| FY2017 | Mar 31, 2017 | $424.09M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $289.00M | +0.4% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $367.10M | -12.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $335.40M | +28.6% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $298.20M | -10.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $287.80M | +14.8% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $420.00M | +38.3% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $260.80M | +2.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $332.80M | +14.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $250.80M | +71.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $303.70M | +8.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $254.83M | +18.1% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $291.24M | +41.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $146.10M | +40.7% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $281.13M | +21.3% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $215.80M | +25.7% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $205.58M | -15.9% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $103.82M | -39.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $231.75M | +137.9% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $171.73M | -8.6% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $244.31M | +18.8% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $171.34M | +5.8% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $97.43M | -27.4% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $187.86M | -5.7% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $205.71M | +56.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $161.95M | +7.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $134.12M | +22.7% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $199.23M | +11.3% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $131.33M | -1.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $150.66M | +19.6% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $109.34M | +8.5% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $178.93M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $133.88M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $125.92M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $100.78M | – |
See a number that looks wrong?